SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biogen Inc. – ‘10-K’ for 12/31/23 – ‘XML’

On:  Tuesday, 2/13/24, at 5:40pm ET   ·   As of:  2/14/24   ·   For:  12/31/23   ·   Accession #:  875045-24-9   ·   File #:  0-19311

Previous ‘10-K’:  ‘10-K’ on 2/15/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   29 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/14/24  Biogen Inc.                       10-K       12/31/23  176:24M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   4.17M 
 2: EX-4.6      Instrument Defining the Rights of Security Holders  HTML     47K 
 3: EX-10.32    Material Contract                                   HTML     48K 
 4: EX-10.33    Material Contract                                   HTML    172K 
 5: EX-10.35    Material Contract                                   HTML     71K 
 6: EX-21       Subsidiaries List                                   HTML     62K 
 7: EX-23       Consent of Expert or Counsel                        HTML     45K 
11: EX-97.1     Clawback Policy re: Recovery of Erroneously         HTML     58K 
                Awarded Compensation                                             
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     50K 
 9: EX-31.2     Certification -- §302 - SOA'02                      HTML     50K 
10: EX-32.1     Certification -- §906 - SOA'02                      HTML     48K 
17: R1          Cover Page                                          HTML    111K 
18: R2          Audit Information                                   HTML     50K 
19: R3          Consolidated Statements of Income                   HTML    143K 
20: R4          Consolidated Statements of Comprehensive Income     HTML     87K 
21: R5          Consolidated Balance Sheets                         HTML    180K 
22: R6          Consolidated Balance Sheets (Parenthetical)         HTML     53K 
23: R7          Consolidated Statements of Cash Flows               HTML    163K 
24: R8          Consolidated Statements of Equity                   HTML    149K 
25: R9          Summary of Significant Accounting Policies          HTML    149K 
26: R10         Acquisitions                                        HTML     99K 
27: R11         Dispositions                                        HTML     55K 
28: R12         Restructuring                                       HTML     88K 
29: R13         Revenue                                             HTML    221K 
30: R14         Inventory                                           HTML     63K 
31: R15         Intangible Assets and Goodwill                      HTML    102K 
32: R16         Fair Value Measurements                             HTML    141K 
33: R17         Financial Instruments                               HTML    117K 
34: R18         Derivative Instruments                              HTML    108K 
35: R19         Property, Plant and Equipment                       HTML     64K 
36: R20         Leases                                              HTML     95K 
37: R21         Indebtedness                                        HTML     86K 
38: R22         Equity                                              HTML    146K 
39: R23         Earnings per Share                                  HTML     64K 
40: R24         Share-Based Payments                                HTML    159K 
41: R25         Income Taxes                                        HTML    144K 
42: R26         Other Consolidated Financial Statement Detail       HTML     92K 
43: R27         Collaborative and Other Relationships               HTML    183K 
44: R28         Investments in Variable Interest Entities           HTML     55K 
45: R29         Litigation                                          HTML     62K 
46: R30         Commitments and Contingencies                       HTML     59K 
47: R31         Guarantees                                          HTML     51K 
48: R32         Employee Benefit Plans                              HTML     56K 
49: R33         Segment Information                                 HTML     99K 
50: R34         Pay vs Performance Disclosure                       HTML     57K 
51: R35         Insider Trading Arrangements                        HTML     68K 
52: R36         Summary of Significant Accounting Policies          HTML    216K 
                (Policies)                                                       
53: R37         Summary of Significant Accounting Policies          HTML     64K 
                (Tables)                                                         
54: R38         Acquisitions (Tables)                               HTML     84K 
55: R39         Restructuring (Tables)                              HTML     86K 
56: R40         Revenue (Tables)                                    HTML    230K 
57: R41         Inventory (Tables)                                  HTML     60K 
58: R42         Intangible Assets and Goodwill (Tables)             HTML     94K 
59: R43         Fair Value Measurements (Tables)                    HTML    134K 
60: R44         Financial Instruments (Tables)                      HTML    119K 
61: R45         Derivative Instruments (Tables)                     HTML    108K 
62: R46         Property, Plant and Equipment (Tables)              HTML     64K 
63: R47         Leases (Tables)                                     HTML     97K 
64: R48         Indebtedness (Tables)                               HTML     71K 
65: R49         Equity (Tables)                                     HTML    140K 
66: R50         Earnings per Share (Tables)                         HTML     61K 
67: R51         Share-Based Payments (Tables)                       HTML    155K 
68: R52         Income Taxes (Tables)                               HTML    131K 
69: R53         Other Consolidated Financial Statement Detail       HTML     94K 
                (Tables)                                                         
70: R54         Collaborative and Other Relationships (Tables)      HTML    132K 
71: R55         Segment Information (Tables)                        HTML     91K 
72: R56         Summary of Significant Accounting Policies -        HTML     87K 
                Narrative (Details)                                              
73: R57         Summary of Significant Accounting Policies -        HTML     60K 
                Summary of Property, Plant and Equipment Estimated               
                Useful Lives (Details)                                           
74: R58         Acquisitions -Narrative (Details)                   HTML    116K 
75: R59         Acquisitions - Purchase Price Consideration         HTML     57K 
                (Details)                                                        
76: R60         Acquisitions Preliminary Purchase Price Allocation  HTML    116K 
                (Details)                                                        
77: R61         Dispositions (Details)                              HTML     96K 
78: R62         Restructuring - Narrative (Details)                 HTML     64K 
79: R63         Restructuring, Business Transformation and Other    HTML     66K 
                Cost Saving Initiatives - Fit for Growth                         
                Initiative (Details)                                             
80: R64         Restructuring, Business Transformation and Other    HTML     67K 
                Cost Saving Initiatives - Total Charges cost                     
                saving initiative (Details)                                      
81: R65         Restructuring - Restructuring Reserve Roll Forward  HTML     58K 
                (Details)                                                        
82: R66         Revenue - Revenues by Product (Details)             HTML    144K 
83: R67         Revenue - Narrative (Details)                       HTML     74K 
84: R68         Revenue - Reserves for Discounts and Allowances     HTML     69K 
                (Details)                                                        
85: R69         Revenue - Total Reserves for Discounts and          HTML     54K 
                Allowances (Details)                                             
86: R70         Revenue - Revenues from Anti-CD20 Therapeutic       HTML     66K 
                Programs (Details)                                               
87: R71         Revenue - Other Revenues (Details)                  HTML     62K 
88: R72         Inventory - Components of Inventory (Details)       HTML     63K 
89: R73         Inventory - Narrative (Details)                     HTML     64K 
90: R74         Intangible Assets and Goodwill - Summary of         HTML     85K 
                Intangible Assets (Details)                                      
91: R75         Intangible Assets and Goodwill - Narrative          HTML    128K 
                (Details)                                                        
92: R76         Intangible Assets and Goodwill - Estimated Future   HTML     56K 
                Amortization of Intangible Assets (Details)                      
93: R77         Intangible Assets and Goodwill - Changes in         HTML     53K 
                Goodwill (Details)                                               
94: R78         Fair Value Measurements - Summary of Assets and     HTML    114K 
                Liabilities Recorded at Fair Value (Details)                     
95: R79         Fair Value Measurements - Narrative (Details)       HTML     84K 
96: R80         Fair Value Measurements - Fair Value of Contingent  HTML     53K 
                Consideration Obligations (Details)                              
97: R81         Fair Value Measurements - Summary of Fair and       HTML     91K 
                Carrying Value of Debt Instruments (Details)                     
98: R82         Financial Instruments - Summary of Financial        HTML     56K 
                Assets with Maturities (Details)                                 
99: R83         Financial Instruments - Summary of Marketable       HTML     90K 
                Securities (Details)                                             
100: R84         Financial Instruments - Summary of Contractual      HTML     66K  
                Maturities (Details)                                             
101: R85         Financial Instruments - Narrative (Details)         HTML     50K  
102: R86         Financial Instruments - Proceeds from Marketable    HTML     52K  
                Debt Securities (Details)                                        
103: R87         Derivative Instruments - Narrative (Details)        HTML     82K  
104: R88         Derivative Instruments - Foreign Currency Forward   HTML     56K  
                Contracts Entered into Hedge Forecasted Revenues                 
                (Details)                                                        
105: R89         Derivative Instruments - Summary of Unrealized      HTML     54K  
                Gain (Loss) on Derivative Instruments Included in                
                AOCI (Details)                                                   
106: R90         Derivative Instruments - Summary of the Effect of   HTML     56K  
                Derivatives Designated as Cash Flow Hedging                      
                Instruments (Details)                                            
107: R91         Derivative Instruments - Summary of the Effect of   HTML     62K  
                Derivatives Designated as Net Investment Hedging                 
                Instruments (Details)                                            
108: R92         Derivative Instruments - Summary of the Fair Value  HTML     60K  
                for our Outstanding Derivatives (Details)                        
109: R93         Property, Plant and Equipment - Components of       HTML     78K  
                property, plant, and equipment, net (Details)                    
110: R94         Property, Plant and Equipment - Narrative           HTML     91K  
                (Details)                                                        
111: R95         Leases - Narrative (Details)                        HTML     82K  
112: R96         Leases - Schedule of Operating Leases (Details)     HTML     59K  
113: R97         Leases - Operating Lease Costs (Details)            HTML     58K  
114: R98         Leases - Operating Lease Liability Maturity         HTML     64K  
                (Details)                                                        
115: R99         Leases - Operating Lease Weighted Average           HTML     49K  
                Remaining Term and Discount Rate (Details)                       
116: R100        Leases - Operating Lease Supplemental Cash Flow     HTML     49K  
                Disclosure (Details)                                             
117: R101        Indebtedness - Summary of Indebtedness (Details)    HTML     84K  
118: R102        Indebtedness - Narrative (Details)                  HTML    149K  
119: R103        Indebtedness - Total Debt Maturities (Details)      HTML     71K  
120: R104        Equity - Narrative (Details)                        HTML     77K  
121: R105        Equity - Summary of Common Stock (Details)          HTML     53K  
122: R106        Equity - Accumulated Other Comprehensive Income     HTML     95K  
                (Loss) (Details)                                                 
123: R107        Equity - Reclassification out of Accumulated Other  HTML     95K  
                Comprehensive Income (Details)                                   
124: R108        Earnings per Share - Basic and Diluted Earnings     HTML     78K  
                Per Share (Details)                                              
125: R109        Earnings per Share - Narrative (Details)            HTML     50K  
126: R110        Share-Based Payments - Share-based Compensation     HTML     63K  
                Expense Included in Consolidation Statements of                  
                Income (Details)                                                 
127: R111        Share-Based Payments - Summary of Share-based       HTML     70K  
                Compensation Expense Associated with Each                        
                Share-based Compensating Programs (Details)                      
128: R112        Share-Based Payments - Narrative (Details)          HTML    144K  
129: R113        Share-Based Payments - Employee Stock Options       HTML     79K  
                (Details)                                                        
130: R114        Share-Based Payments - Market Stock Units Activity  HTML     70K  
                (Details)                                                        
131: R115        Share-Based Payments - Assumptions Used in          HTML     73K  
                Valuation of Market Based Stock Units (Details)                  
132: R116        Share-Based Payments - Performance Stock Units      HTML     70K  
                Settled in Stock Activity (Details)                              
133: R117        Share-Based Payments - Assumptions Used in          HTML     73K  
                Valuation of Performance Shares (Details)                        
134: R118        Share-Based Payments - Performance Stock Units      HTML     59K  
                Settled in Cash Activity (Details)                               
135: R119        Share-Based Payments - Time-Vested Restricted       HTML     74K  
                Stock Units Activity (Details)                                   
136: R120        Share-Based Payments - Shares Issued Under          HTML     54K  
                Employee Stock Purchase Plan (Details)                           
137: R121        Income Taxes - Income Before Income Tax Provision   HTML     84K  
                and the Income Tax Expense (Details)                             
138: R122        Income Taxes - Narrative (Details)                  HTML    107K  
139: R123        Income Taxes - Components of Deferred Tax Assets    HTML     82K  
                and Liabilities (Details)                                        
140: R124        Income Taxes - Tax Rate (Details)                   HTML     73K  
141: R125        Income Taxes - Accounting for Uncertainty in        HTML     59K  
                Income Taxes (Details)                                           
142: R126        Other Consolidated Financial Statement Detail -     HTML     50K  
                Supplemental Cash Flow Information (Details)                     
143: R127        Other Consolidated Financial Statement Detail -     HTML     71K  
                Other Income (Expense), Net (Details)                            
144: R128        Other Consolidated Financial Statement Detail -     HTML     61K  
                Narrative (Details)                                              
145: R129        Other Consolidated Financial Statement Detail -     HTML     52K  
                Gain (Loss) on Investments (Details)                             
146: R130        Other Consolidated Financial Statement Detail -     HTML     64K  
                Accrued Expense and Other (Details)                              
147: R131        Collaborative and Other Relationships - OCREVUS     HTML     59K  
                (Details)                                                        
148: R132        Collaborative and Other Relationships -             HTML     57K  
                Mosunetuzumab (Details)                                          
149: R133        Collaborative and Other Relationships -             HTML     52K  
                Co-promotion Profit Sharing Formula (Details)                    
150: R134        Collaborative and Other Relationships - Profit      HTML     65K  
                Sharing (Details)                                                
151: R135        Collaborative and Other Relationships - Pretax      HTML     51K  
                Profit Sharing Formula (Details)                                 
152: R136        Collaborative and Other Relationships - Revenues    HTML     64K  
                from Anti-CD20 Therapeutic Programs (Details)                    
153: R137        Collaborative and Other Relationships - Ionis       HTML    113K  
                (Details)                                                        
154: R138        Collaborative and Other Relationships - Eisai       HTML     62K  
                (Details)                                                        
155: R139        Collaborative and Other Relationships - Summary of  HTML     56K  
                Activity Related to BAN2401 and Elenbecestat                     
                Collaboration (Details)                                          
156: R140        Collaborative and Other Relationships - ADUHELM     HTML     86K  
                Collaboration Agreement (Details)                                
157: R141        Collaborative and Other Relationships - Summary of  HTML     63K  
                Activity Related to Aducanumab Collaboration                     
                (Details)                                                        
158: R142        Collaborative and Other Relationships - Summary of  HTML     51K  
                Activity Related to the UCB Collaboration                        
                (Details)                                                        
159: R143        Collaborative and Other Relationships - Alkermes    HTML     55K  
                (Details)                                                        
160: R144        Collaborative and Other Relationships - Acorda      HTML     49K  
                (Details)                                                        
161: R145        Collaborative and Other Relationships - Other       HTML     85K  
                Arrangements (Details)                                           
162: R146        Collaborative and Other Relationships - Summary of  HTML     55K  
                Activity Related to Sage Therapeutics (Details)                  
163: R147        Collaborative and Other Relationships - Summary of  HTML     51K  
                Activity Related To Denali Therapeutics (Details)                
164: R148        Collaborative and Other Relationships - Summary of  HTML     51K  
                Activity Related to Sangamo Therapeutics (Details)               
165: R149        Collaborative and Other Relationships - Samsung     HTML    146K  
                Bioepis (Details)                                                
166: R150        Investments in Variable Interest Entities           HTML     79K  
                (Details)                                                        
167: R151        Litigation (Details)                                HTML     64K  
168: R152        Commitments and Contingencies (Details)             HTML    111K  
169: R153        Employee Benefit Plans (Details)                    HTML     73K  
170: R154        Segment Information - Narrative (Details)           HTML     52K  
171: R155        Segment Information - Geographic Information        HTML     90K  
                (Details)                                                        
173: XML         IDEA XML File -- Filing Summary                      XML    336K  
176: XML         XBRL Instance -- biib-20231231_htm                   XML   5.47M  
172: EXCEL       IDEA Workbook of Financial Report Info              XLSX    408K  
13: EX-101.CAL  XBRL Calculations -- biib-20231231_cal               XML    381K 
14: EX-101.DEF  XBRL Definitions -- biib-20231231_def                XML   2.21M 
15: EX-101.LAB  XBRL Labels -- biib-20231231_lab                     XML   3.89M 
16: EX-101.PRE  XBRL Presentations -- biib-20231231_pre              XML   2.94M 
12: EX-101.SCH  XBRL Schema -- biib-20231231                         XSD    451K 
174: JSON        XBRL Instance as JSON Data -- MetaLinks              968±  1.49M  
175: ZIP         XBRL Zipped Folder -- 0000875045-24-000009-xbrl      Zip   2.28M

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.24.0.1 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 923 </ContextCount>
<ElementCount> 719 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 233 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 13 </UnitCount>
<MyReports>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 0000001 - Document - Cover Page </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CoverPage </Role>
<ShortName> Cover Page </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 0000002 - Document - Audit Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/AuditInformation </Role>
<ShortName> Audit Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 0000003 - Statement - Consolidated Statements of Income </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ConsolidatedStatementsofIncome </Role>
<ShortName> Consolidated Statements of Income </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 0000004 - Statement - Consolidated Statements of Comprehensive Income </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ConsolidatedStatementsofComprehensiveIncome </Role>
<ShortName> Consolidated Statements of Comprehensive Income </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 0000005 - Statement - Consolidated Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ConsolidatedBalanceSheets </Role>
<ShortName> Consolidated Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 0000006 - Statement - Consolidated Balance Sheets (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ConsolidatedBalanceSheetsParenthetical </Role>
<ShortName> Consolidated Balance Sheets (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 0000007 - Statement - Consolidated Statements of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ConsolidatedStatementsofCashFlows </Role>
<ShortName> Consolidated Statements of Cash Flows </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 0000008 - Statement - Consolidated Statements of Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ConsolidatedStatementsofEquity </Role>
<ShortName> Consolidated Statements of Equity </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 0000009 - Disclosure - Summary of Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/SummaryofSignificantAccountingPolicies </Role>
<ShortName> Summary of Significant Accounting Policies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 0000010 - Disclosure - Acquisitions </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/Acquisitions </Role>
<ShortName> Acquisitions </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 0000011 - Disclosure - Dispositions </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/Dispositions </Role>
<ShortName> Dispositions </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 0000012 - Disclosure - Restructuring </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/Restructuring </Role>
<ShortName> Restructuring </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 0000013 - Disclosure - Revenue </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/Revenue </Role>
<ShortName> Revenue </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 0000014 - Disclosure - Inventory </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/Inventory </Role>
<ShortName> Inventory </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 0000015 - Disclosure - Intangible Assets and Goodwill </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IntangibleAssetsandGoodwill </Role>
<ShortName> Intangible Assets and Goodwill </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 0000016 - Disclosure - Fair Value Measurements </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/FairValueMeasurements </Role>
<ShortName> Fair Value Measurements </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 0000017 - Disclosure - Financial Instruments </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/FinancialInstruments </Role>
<ShortName> Financial Instruments </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 0000018 - Disclosure - Derivative Instruments </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/DerivativeInstruments </Role>
<ShortName> Derivative Instruments </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 0000019 - Disclosure - Property, Plant and Equipment </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/PropertyPlantandEquipment </Role>
<ShortName> Property, Plant and Equipment </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 19 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 0000020 - Disclosure - Leases </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/Leases </Role>
<ShortName> Leases </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 20 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 0000021 - Disclosure - Indebtedness </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/Indebtedness </Role>
<ShortName> Indebtedness </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 21 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 0000022 - Disclosure - Equity </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/Equity </Role>
<ShortName> Equity </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 22 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 0000023 - Disclosure - Earnings per Share </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/EarningsperShare </Role>
<ShortName> Earnings per Share </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 23 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 0000024 - Disclosure - Share-Based Payments </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ShareBasedPayments </Role>
<ShortName> Share-Based Payments </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 24 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 0000025 - Disclosure - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IncomeTaxes </Role>
<ShortName> Income Taxes </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 25 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 0000026 - Disclosure - Other Consolidated Financial Statement Detail </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetail </Role>
<ShortName> Other Consolidated Financial Statement Detail </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 26 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 0000027 - Disclosure - Collaborative and Other Relationships </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationships </Role>
<ShortName> Collaborative and Other Relationships </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 27 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 0000028 - Disclosure - Investments in Variable Interest Entities </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/InvestmentsinVariableInterestEntities </Role>
<ShortName> Investments in Variable Interest Entities </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 28 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 0000029 - Disclosure - Litigation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/Litigation </Role>
<ShortName> Litigation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 29 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 0000030 - Disclosure - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CommitmentsandContingencies </Role>
<ShortName> Commitments and Contingencies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 30 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 0000031 - Disclosure - Guarantees </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/Guarantees </Role>
<ShortName> Guarantees </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 31 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 0000032 - Disclosure - Employee Benefit Plans </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/EmployeeBenefitPlans </Role>
<ShortName> Employee Benefit Plans </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 32 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 0000033 - Disclosure - Segment Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/SegmentInformation </Role>
<ShortName> Segment Information </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 33 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 995410 - Disclosure - Pay vs Performance Disclosure </LongName>
<ReportType> Sheet </ReportType>
<Role> http://xbrl.sec.gov/ecd/role/PvpDisclosure </Role>
<ShortName> Pay vs Performance Disclosure </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 34 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 995445 - Disclosure - Insider Trading Arrangements </LongName>
<ReportType> Sheet </ReportType>
<Role> http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements </Role>
<ShortName> Insider Trading Arrangements </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 35 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 9954471 - Disclosure - Summary of Significant Accounting Policies (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/SummaryofSignificantAccountingPoliciesPolicies </Role>
<ShortName> Summary of Significant Accounting Policies (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/SummaryofSignificantAccountingPolicies </ParentRole>
<Position> 36 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 9954472 - Disclosure - Summary of Significant Accounting Policies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/SummaryofSignificantAccountingPoliciesTables </Role>
<ShortName> Summary of Significant Accounting Policies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/SummaryofSignificantAccountingPolicies </ParentRole>
<Position> 37 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 9954473 - Disclosure - Acquisitions (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/AcquisitionsTables </Role>
<ShortName> Acquisitions (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/Acquisitions </ParentRole>
<Position> 38 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 9954474 - Disclosure - Restructuring (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/RestructuringTables </Role>
<ShortName> Restructuring (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/Restructuring </ParentRole>
<Position> 39 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 9954475 - Disclosure - Revenue (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/RevenueTables </Role>
<ShortName> Revenue (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/Revenue </ParentRole>
<Position> 40 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 9954476 - Disclosure - Inventory (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/InventoryTables </Role>
<ShortName> Inventory (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/Inventory </ParentRole>
<Position> 41 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 9954477 - Disclosure - Intangible Assets and Goodwill (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IntangibleAssetsandGoodwillTables </Role>
<ShortName> Intangible Assets and Goodwill (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/IntangibleAssetsandGoodwill </ParentRole>
<Position> 42 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 9954478 - Disclosure - Fair Value Measurements (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/FairValueMeasurementsTables </Role>
<ShortName> Fair Value Measurements (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/FairValueMeasurements </ParentRole>
<Position> 43 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 9954479 - Disclosure - Financial Instruments (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/FinancialInstrumentsTables </Role>
<ShortName> Financial Instruments (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/FinancialInstruments </ParentRole>
<Position> 44 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 9954480 - Disclosure - Derivative Instruments (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/DerivativeInstrumentsTables </Role>
<ShortName> Derivative Instruments (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/DerivativeInstruments </ParentRole>
<Position> 45 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 9954481 - Disclosure - Property, Plant and Equipment (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/PropertyPlantandEquipmentTables </Role>
<ShortName> Property, Plant and Equipment (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/PropertyPlantandEquipment </ParentRole>
<Position> 46 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R47.htm </HtmlFileName>
<LongName> 9954482 - Disclosure - Leases (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/LeasesTables </Role>
<ShortName> Leases (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/Leases </ParentRole>
<Position> 47 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R48.htm </HtmlFileName>
<LongName> 9954483 - Disclosure - Indebtedness (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IndebtednessTables </Role>
<ShortName> Indebtedness (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/Indebtedness </ParentRole>
<Position> 48 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R49.htm </HtmlFileName>
<LongName> 9954484 - Disclosure - Equity (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/EquityTables </Role>
<ShortName> Equity (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/Equity </ParentRole>
<Position> 49 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R50.htm </HtmlFileName>
<LongName> 9954485 - Disclosure - Earnings per Share (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/EarningsperShareTables </Role>
<ShortName> Earnings per Share (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/EarningsperShare </ParentRole>
<Position> 50 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R51.htm </HtmlFileName>
<LongName> 9954486 - Disclosure - Share-Based Payments (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ShareBasedPaymentsTables </Role>
<ShortName> Share-Based Payments (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/ShareBasedPayments </ParentRole>
<Position> 51 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R52.htm </HtmlFileName>
<LongName> 9954487 - Disclosure - Income Taxes (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IncomeTaxesTables </Role>
<ShortName> Income Taxes (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/IncomeTaxes </ParentRole>
<Position> 52 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R53.htm </HtmlFileName>
<LongName> 9954488 - Disclosure - Other Consolidated Financial Statement Detail (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailTables </Role>
<ShortName> Other Consolidated Financial Statement Detail (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetail </ParentRole>
<Position> 53 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R54.htm </HtmlFileName>
<LongName> 9954489 - Disclosure - Collaborative and Other Relationships (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsTables </Role>
<ShortName> Collaborative and Other Relationships (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/CollaborativeandOtherRelationships </ParentRole>
<Position> 54 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R55.htm </HtmlFileName>
<LongName> 9954490 - Disclosure - Segment Information (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/SegmentInformationTables </Role>
<ShortName> Segment Information (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/SegmentInformation </ParentRole>
<Position> 55 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R56.htm </HtmlFileName>
<LongName> 9954491 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails </Role>
<ShortName> Summary of Significant Accounting Policies - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 56 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R57.htm </HtmlFileName>
<LongName> 9954492 - Disclosure - Summary of Significant Accounting Policies - Summary of Property, Plant and Equipment Estimated Useful Lives (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/SummaryofSignificantAccountingPoliciesSummaryofPropertyPlantandEquipmentEstimatedUsefulLivesDetails </Role>
<ShortName> Summary of Significant Accounting Policies - Summary of Property, Plant and Equipment Estimated Useful Lives (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 57 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R58.htm </HtmlFileName>
<LongName> 9954493 - Disclosure - Acquisitions -Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/AcquisitionsNarrativeDetails </Role>
<ShortName> Acquisitions -Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 58 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R59.htm </HtmlFileName>
<LongName> 9954494 - Disclosure - Acquisitions - Purchase Price Consideration (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/AcquisitionsPurchasePriceConsiderationDetails </Role>
<ShortName> Acquisitions - Purchase Price Consideration (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 59 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R60.htm </HtmlFileName>
<LongName> 9954495 - Disclosure - Acquisitions Preliminary Purchase Price Allocation (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/AcquisitionsPreliminaryPurchasePriceAllocationDetails </Role>
<ShortName> Acquisitions Preliminary Purchase Price Allocation (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 60 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R61.htm </HtmlFileName>
<LongName> 9954496 - Disclosure - Dispositions (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/DispositionsDetails </Role>
<ShortName> Dispositions (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/Dispositions </ParentRole>
<Position> 61 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R62.htm </HtmlFileName>
<LongName> 9954497 - Disclosure - Restructuring - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/RestructuringNarrativeDetails </Role>
<ShortName> Restructuring - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 62 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R63.htm </HtmlFileName>
<LongName> 9954498 - Disclosure - Restructuring, Business Transformation and Other Cost Saving Initiatives - Fit for Growth Initiative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/RestructuringBusinessTransformationandOtherCostSavingInitiativesFitforGrowthInitiativeDetails </Role>
<ShortName> Restructuring, Business Transformation and Other Cost Saving Initiatives - Fit for Growth Initiative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 63 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R64.htm </HtmlFileName>
<LongName> 9954499 - Disclosure - Restructuring, Business Transformation and Other Cost Saving Initiatives - Total Charges cost saving initiative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/RestructuringBusinessTransformationandOtherCostSavingInitiativesTotalChargescostsavinginitiativeDetails </Role>
<ShortName> Restructuring, Business Transformation and Other Cost Saving Initiatives - Total Charges cost saving initiative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 64 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R65.htm </HtmlFileName>
<LongName> 9954500 - Disclosure - Restructuring - Restructuring Reserve Roll Forward (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/RestructuringRestructuringReserveRollForwardDetails </Role>
<ShortName> Restructuring - Restructuring Reserve Roll Forward (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 65 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R66.htm </HtmlFileName>
<LongName> 9954501 - Disclosure - Revenue - Revenues by Product (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/RevenueRevenuesbyProductDetails </Role>
<ShortName> Revenue - Revenues by Product (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 66 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R67.htm </HtmlFileName>
<LongName> 9954502 - Disclosure - Revenue - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/RevenueNarrativeDetails </Role>
<ShortName> Revenue - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 67 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R68.htm </HtmlFileName>
<LongName> 9954503 - Disclosure - Revenue - Reserves for Discounts and Allowances (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/RevenueReservesforDiscountsandAllowancesDetails </Role>
<ShortName> Revenue - Reserves for Discounts and Allowances (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 68 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R69.htm </HtmlFileName>
<LongName> 9954504 - Disclosure - Revenue - Total Reserves for Discounts and Allowances (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/RevenueTotalReservesforDiscountsandAllowancesDetails </Role>
<ShortName> Revenue - Total Reserves for Discounts and Allowances (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 69 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R70.htm </HtmlFileName>
<LongName> 9954505 - Disclosure - Revenue - Revenues from Anti-CD20 Therapeutic Programs (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/RevenueRevenuesfromAntiCD20TherapeuticProgramsDetails </Role>
<ShortName> Revenue - Revenues from Anti-CD20 Therapeutic Programs (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 70 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R71.htm </HtmlFileName>
<LongName> 9954506 - Disclosure - Revenue - Other Revenues (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/RevenueOtherRevenuesDetails </Role>
<ShortName> Revenue - Other Revenues (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 71 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R72.htm </HtmlFileName>
<LongName> 9954507 - Disclosure - Inventory - Components of Inventory (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/InventoryComponentsofInventoryDetails </Role>
<ShortName> Inventory - Components of Inventory (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 72 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R73.htm </HtmlFileName>
<LongName> 9954508 - Disclosure - Inventory - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/InventoryNarrativeDetails </Role>
<ShortName> Inventory - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 73 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R74.htm </HtmlFileName>
<LongName> 9954509 - Disclosure - Intangible Assets and Goodwill - Summary of Intangible Assets (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IntangibleAssetsandGoodwillSummaryofIntangibleAssetsDetails </Role>
<ShortName> Intangible Assets and Goodwill - Summary of Intangible Assets (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 74 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R75.htm </HtmlFileName>
<LongName> 9954510 - Disclosure - Intangible Assets and Goodwill - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IntangibleAssetsandGoodwillNarrativeDetails </Role>
<ShortName> Intangible Assets and Goodwill - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 75 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R76.htm </HtmlFileName>
<LongName> 9954511 - Disclosure - Intangible Assets and Goodwill - Estimated Future Amortization of Intangible Assets (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IntangibleAssetsandGoodwillEstimatedFutureAmortizationofIntangibleAssetsDetails </Role>
<ShortName> Intangible Assets and Goodwill - Estimated Future Amortization of Intangible Assets (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 76 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R77.htm </HtmlFileName>
<LongName> 9954512 - Disclosure - Intangible Assets and Goodwill - Changes in Goodwill (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IntangibleAssetsandGoodwillChangesinGoodwillDetails </Role>
<ShortName> Intangible Assets and Goodwill - Changes in Goodwill (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 77 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R78.htm </HtmlFileName>
<LongName> 9954513 - Disclosure - Fair Value Measurements - Summary of Assets and Liabilities Recorded at Fair Value (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/FairValueMeasurementsSummaryofAssetsandLiabilitiesRecordedatFairValueDetails </Role>
<ShortName> Fair Value Measurements - Summary of Assets and Liabilities Recorded at Fair Value (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 78 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R79.htm </HtmlFileName>
<LongName> 9954514 - Disclosure - Fair Value Measurements - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/FairValueMeasurementsNarrativeDetails </Role>
<ShortName> Fair Value Measurements - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 79 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R80.htm </HtmlFileName>
<LongName> 9954515 - Disclosure - Fair Value Measurements - Fair Value of Contingent Consideration Obligations (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/FairValueMeasurementsFairValueofContingentConsiderationObligationsDetails </Role>
<ShortName> Fair Value Measurements - Fair Value of Contingent Consideration Obligations (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 80 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R81.htm </HtmlFileName>
<LongName> 9954516 - Disclosure - Fair Value Measurements - Summary of Fair and Carrying Value of Debt Instruments (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/FairValueMeasurementsSummaryofFairandCarryingValueofDebtInstrumentsDetails </Role>
<ShortName> Fair Value Measurements - Summary of Fair and Carrying Value of Debt Instruments (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 81 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R82.htm </HtmlFileName>
<LongName> 9954517 - Disclosure - Financial Instruments - Summary of Financial Assets with Maturities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/FinancialInstrumentsSummaryofFinancialAssetswithMaturitiesDetails </Role>
<ShortName> Financial Instruments - Summary of Financial Assets with Maturities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 82 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R83.htm </HtmlFileName>
<LongName> 9954518 - Disclosure - Financial Instruments - Summary of Marketable Securities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/FinancialInstrumentsSummaryofMarketableSecuritiesDetails </Role>
<ShortName> Financial Instruments - Summary of Marketable Securities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 83 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R84.htm </HtmlFileName>
<LongName> 9954519 - Disclosure - Financial Instruments - Summary of Contractual Maturities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/FinancialInstrumentsSummaryofContractualMaturitiesDetails </Role>
<ShortName> Financial Instruments - Summary of Contractual Maturities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 84 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R85.htm </HtmlFileName>
<LongName> 9954520 - Disclosure - Financial Instruments - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/FinancialInstrumentsNarrativeDetails </Role>
<ShortName> Financial Instruments - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 85 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R86.htm </HtmlFileName>
<LongName> 9954521 - Disclosure - Financial Instruments - Proceeds from Marketable Debt Securities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/FinancialInstrumentsProceedsfromMarketableDebtSecuritiesDetails </Role>
<ShortName> Financial Instruments - Proceeds from Marketable Debt Securities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 86 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R87.htm </HtmlFileName>
<LongName> 9954522 - Disclosure - Derivative Instruments - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/DerivativeInstrumentsNarrativeDetails </Role>
<ShortName> Derivative Instruments - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 87 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R88.htm </HtmlFileName>
<LongName> 9954523 - Disclosure - Derivative Instruments - Foreign Currency Forward Contracts Entered into Hedge Forecasted Revenues (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/DerivativeInstrumentsForeignCurrencyForwardContractsEnteredintoHedgeForecastedRevenuesDetails </Role>
<ShortName> Derivative Instruments - Foreign Currency Forward Contracts Entered into Hedge Forecasted Revenues (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 88 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R89.htm </HtmlFileName>
<LongName> 9954524 - Disclosure - Derivative Instruments - Summary of Unrealized Gain (Loss) on Derivative Instruments Included in AOCI (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/DerivativeInstrumentsSummaryofUnrealizedGainLossonDerivativeInstrumentsIncludedinAOCIDetails </Role>
<ShortName> Derivative Instruments - Summary of Unrealized Gain (Loss) on Derivative Instruments Included in AOCI (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 89 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R90.htm </HtmlFileName>
<LongName> 9954525 - Disclosure - Derivative Instruments - Summary of the Effect of Derivatives Designated as Cash Flow Hedging Instruments (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/DerivativeInstrumentsSummaryoftheEffectofDerivativesDesignatedasCashFlowHedgingInstrumentsDetails </Role>
<ShortName> Derivative Instruments - Summary of the Effect of Derivatives Designated as Cash Flow Hedging Instruments (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 90 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R91.htm </HtmlFileName>
<LongName> 9954526 - Disclosure - Derivative Instruments - Summary of the Effect of Derivatives Designated as Net Investment Hedging Instruments (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/DerivativeInstrumentsSummaryoftheEffectofDerivativesDesignatedasNetInvestmentHedgingInstrumentsDetails </Role>
<ShortName> Derivative Instruments - Summary of the Effect of Derivatives Designated as Net Investment Hedging Instruments (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 91 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R92.htm </HtmlFileName>
<LongName> 9954527 - Disclosure - Derivative Instruments - Summary of the Fair Value for our Outstanding Derivatives (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/DerivativeInstrumentsSummaryoftheFairValueforourOutstandingDerivativesDetails </Role>
<ShortName> Derivative Instruments - Summary of the Fair Value for our Outstanding Derivatives (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 92 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R93.htm </HtmlFileName>
<LongName> 9954528 - Disclosure - Property, Plant and Equipment - Components of property, plant, and equipment, net (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/PropertyPlantandEquipmentComponentsofpropertyplantandequipmentnetDetails </Role>
<ShortName> Property, Plant and Equipment - Components of property, plant, and equipment, net (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 93 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R94.htm </HtmlFileName>
<LongName> 9954529 - Disclosure - Property, Plant and Equipment - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/PropertyPlantandEquipmentNarrativeDetails </Role>
<ShortName> Property, Plant and Equipment - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 94 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R95.htm </HtmlFileName>
<LongName> 9954530 - Disclosure - Leases - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/LeasesNarrativeDetails </Role>
<ShortName> Leases - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 95 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R96.htm </HtmlFileName>
<LongName> 9954531 - Disclosure - Leases - Schedule of Operating Leases (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/LeasesScheduleofOperatingLeasesDetails </Role>
<ShortName> Leases - Schedule of Operating Leases (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 96 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R97.htm </HtmlFileName>
<LongName> 9954532 - Disclosure - Leases - Operating Lease Costs (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/LeasesOperatingLeaseCostsDetails </Role>
<ShortName> Leases - Operating Lease Costs (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 97 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R98.htm </HtmlFileName>
<LongName> 9954533 - Disclosure - Leases - Operating Lease Liability Maturity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/LeasesOperatingLeaseLiabilityMaturityDetails </Role>
<ShortName> Leases - Operating Lease Liability Maturity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 98 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R99.htm </HtmlFileName>
<LongName> 9954534 - Disclosure - Leases - Operating Lease Weighted Average Remaining Term and Discount Rate (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/LeasesOperatingLeaseWeightedAverageRemainingTermandDiscountRateDetails </Role>
<ShortName> Leases - Operating Lease Weighted Average Remaining Term and Discount Rate (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 99 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R100.htm </HtmlFileName>
<LongName> 9954535 - Disclosure - Leases - Operating Lease Supplemental Cash Flow Disclosure (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/LeasesOperatingLeaseSupplementalCashFlowDisclosureDetails </Role>
<ShortName> Leases - Operating Lease Supplemental Cash Flow Disclosure (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 100 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R101.htm </HtmlFileName>
<LongName> 9954536 - Disclosure - Indebtedness - Summary of Indebtedness (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IndebtednessSummaryofIndebtednessDetails </Role>
<ShortName> Indebtedness - Summary of Indebtedness (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 101 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R102.htm </HtmlFileName>
<LongName> 9954537 - Disclosure - Indebtedness - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IndebtednessNarrativeDetails </Role>
<ShortName> Indebtedness - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 102 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R103.htm </HtmlFileName>
<LongName> 9954538 - Disclosure - Indebtedness - Total Debt Maturities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IndebtednessTotalDebtMaturitiesDetails </Role>
<ShortName> Indebtedness - Total Debt Maturities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 103 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R104.htm </HtmlFileName>
<LongName> 9954539 - Disclosure - Equity - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/EquityNarrativeDetails </Role>
<ShortName> Equity - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 104 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R105.htm </HtmlFileName>
<LongName> 9954540 - Disclosure - Equity - Summary of Common Stock (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/EquitySummaryofCommonStockDetails </Role>
<ShortName> Equity - Summary of Common Stock (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 105 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R106.htm </HtmlFileName>
<LongName> 9954541 - Disclosure - Equity - Accumulated Other Comprehensive Income (Loss) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/EquityAccumulatedOtherComprehensiveIncomeLossDetails </Role>
<ShortName> Equity - Accumulated Other Comprehensive Income (Loss) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 106 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R107.htm </HtmlFileName>
<LongName> 9954542 - Disclosure - Equity - Reclassification out of Accumulated Other Comprehensive Income (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/EquityReclassificationoutofAccumulatedOtherComprehensiveIncomeDetails </Role>
<ShortName> Equity - Reclassification out of Accumulated Other Comprehensive Income (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 107 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R108.htm </HtmlFileName>
<LongName> 9954543 - Disclosure - Earnings per Share - Basic and Diluted Earnings Per Share (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/EarningsperShareBasicandDilutedEarningsPerShareDetails </Role>
<ShortName> Earnings per Share - Basic and Diluted Earnings Per Share (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 108 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R109.htm </HtmlFileName>
<LongName> 9954544 - Disclosure - Earnings per Share - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/EarningsperShareNarrativeDetails </Role>
<ShortName> Earnings per Share - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 109 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R110.htm </HtmlFileName>
<LongName> 9954545 - Disclosure - Share-Based Payments - Share-based Compensation Expense Included in Consolidation Statements of Income (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ShareBasedPaymentsSharebasedCompensationExpenseIncludedinConsolidationStatementsofIncomeDetails </Role>
<ShortName> Share-Based Payments - Share-based Compensation Expense Included in Consolidation Statements of Income (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 110 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R111.htm </HtmlFileName>
<LongName> 9954546 - Disclosure - Share-Based Payments - Summary of Share-based Compensation Expense Associated with Each Share-based Compensating Programs (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ShareBasedPaymentsSummaryofSharebasedCompensationExpenseAssociatedwithEachSharebasedCompensatingProgramsDetails </Role>
<ShortName> Share-Based Payments - Summary of Share-based Compensation Expense Associated with Each Share-based Compensating Programs (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 111 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R112.htm </HtmlFileName>
<LongName> 9954547 - Disclosure - Share-Based Payments - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ShareBasedPaymentsNarrativeDetails </Role>
<ShortName> Share-Based Payments - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 112 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R113.htm </HtmlFileName>
<LongName> 9954548 - Disclosure - Share-Based Payments - Employee Stock Options (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ShareBasedPaymentsEmployeeStockOptionsDetails </Role>
<ShortName> Share-Based Payments - Employee Stock Options (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 113 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R114.htm </HtmlFileName>
<LongName> 9954549 - Disclosure - Share-Based Payments - Market Stock Units Activity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ShareBasedPaymentsMarketStockUnitsActivityDetails </Role>
<ShortName> Share-Based Payments - Market Stock Units Activity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 114 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R115.htm </HtmlFileName>
<LongName> 9954550 - Disclosure - Share-Based Payments - Assumptions Used in Valuation of Market Based Stock Units (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ShareBasedPaymentsAssumptionsUsedinValuationofMarketBasedStockUnitsDetails </Role>
<ShortName> Share-Based Payments - Assumptions Used in Valuation of Market Based Stock Units (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 115 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R116.htm </HtmlFileName>
<LongName> 9954551 - Disclosure - Share-Based Payments - Performance Stock Units Settled in Stock Activity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ShareBasedPaymentsPerformanceStockUnitsSettledinStockActivityDetails </Role>
<ShortName> Share-Based Payments - Performance Stock Units Settled in Stock Activity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 116 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R117.htm </HtmlFileName>
<LongName> 9954552 - Disclosure - Share-Based Payments - Assumptions Used in Valuation of Performance Shares (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ShareBasedPaymentsAssumptionsUsedinValuationofPerformanceSharesDetails </Role>
<ShortName> Share-Based Payments - Assumptions Used in Valuation of Performance Shares (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 117 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R118.htm </HtmlFileName>
<LongName> 9954553 - Disclosure - Share-Based Payments - Performance Stock Units Settled in Cash Activity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ShareBasedPaymentsPerformanceStockUnitsSettledinCashActivityDetails </Role>
<ShortName> Share-Based Payments - Performance Stock Units Settled in Cash Activity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 118 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R119.htm </HtmlFileName>
<LongName> 9954554 - Disclosure - Share-Based Payments - Time-Vested Restricted Stock Units Activity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ShareBasedPaymentsTimeVestedRestrictedStockUnitsActivityDetails </Role>
<ShortName> Share-Based Payments - Time-Vested Restricted Stock Units Activity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 119 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R120.htm </HtmlFileName>
<LongName> 9954555 - Disclosure - Share-Based Payments - Shares Issued Under Employee Stock Purchase Plan (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/ShareBasedPaymentsSharesIssuedUnderEmployeeStockPurchasePlanDetails </Role>
<ShortName> Share-Based Payments - Shares Issued Under Employee Stock Purchase Plan (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 120 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R121.htm </HtmlFileName>
<LongName> 9954556 - Disclosure - Income Taxes - Income Before Income Tax Provision and the Income Tax Expense (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IncomeTaxesIncomeBeforeIncomeTaxProvisionandtheIncomeTaxExpenseDetails </Role>
<ShortName> Income Taxes - Income Before Income Tax Provision and the Income Tax Expense (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 121 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R122.htm </HtmlFileName>
<LongName> 9954557 - Disclosure - Income Taxes - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IncomeTaxesNarrativeDetails </Role>
<ShortName> Income Taxes - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 122 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R123.htm </HtmlFileName>
<LongName> 9954558 - Disclosure - Income Taxes - Components of Deferred Tax Assets and Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IncomeTaxesComponentsofDeferredTaxAssetsandLiabilitiesDetails </Role>
<ShortName> Income Taxes - Components of Deferred Tax Assets and Liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 123 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R124.htm </HtmlFileName>
<LongName> 9954559 - Disclosure - Income Taxes - Tax Rate (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IncomeTaxesTaxRateDetails </Role>
<ShortName> Income Taxes - Tax Rate (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 124 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R125.htm </HtmlFileName>
<LongName> 9954560 - Disclosure - Income Taxes - Accounting for Uncertainty in Income Taxes (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/IncomeTaxesAccountingforUncertaintyinIncomeTaxesDetails </Role>
<ShortName> Income Taxes - Accounting for Uncertainty in Income Taxes (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 125 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R126.htm </HtmlFileName>
<LongName> 9954561 - Disclosure - Other Consolidated Financial Statement Detail - Supplemental Cash Flow Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailSupplementalCashFlowInformationDetails </Role>
<ShortName> Other Consolidated Financial Statement Detail - Supplemental Cash Flow Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 126 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R127.htm </HtmlFileName>
<LongName> 9954562 - Disclosure - Other Consolidated Financial Statement Detail - Other Income (Expense), Net (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailOtherIncomeExpenseNetDetails </Role>
<ShortName> Other Consolidated Financial Statement Detail - Other Income (Expense), Net (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 127 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R128.htm </HtmlFileName>
<LongName> 9954563 - Disclosure - Other Consolidated Financial Statement Detail - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailNarrativeDetails </Role>
<ShortName> Other Consolidated Financial Statement Detail - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 128 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R129.htm </HtmlFileName>
<LongName> 9954564 - Disclosure - Other Consolidated Financial Statement Detail - Gain (Loss) on Investments (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailGainLossonInvestmentsDetails </Role>
<ShortName> Other Consolidated Financial Statement Detail - Gain (Loss) on Investments (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailTables </ParentRole>
<Position> 129 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R130.htm </HtmlFileName>
<LongName> 9954565 - Disclosure - Other Consolidated Financial Statement Detail - Accrued Expense and Other (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/OtherConsolidatedFinancialStatementDetailAccruedExpenseandOtherDetails </Role>
<ShortName> Other Consolidated Financial Statement Detail - Accrued Expense and Other (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 130 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R131.htm </HtmlFileName>
<LongName> 9954566 - Disclosure - Collaborative and Other Relationships - OCREVUS (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsOCREVUSDetails </Role>
<ShortName> Collaborative and Other Relationships - OCREVUS (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 131 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R132.htm </HtmlFileName>
<LongName> 9954567 - Disclosure - Collaborative and Other Relationships - Mosunetuzumab (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsMosunetuzumabDetails </Role>
<ShortName> Collaborative and Other Relationships - Mosunetuzumab (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 132 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R133.htm </HtmlFileName>
<LongName> 9954568 - Disclosure - Collaborative and Other Relationships - Co-promotion Profit Sharing Formula (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsCopromotionProfitSharingFormulaDetails </Role>
<ShortName> Collaborative and Other Relationships - Co-promotion Profit Sharing Formula (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 133 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R134.htm </HtmlFileName>
<LongName> 9954569 - Disclosure - Collaborative and Other Relationships - Profit Sharing (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsProfitSharingDetails </Role>
<ShortName> Collaborative and Other Relationships - Profit Sharing (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 134 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R135.htm </HtmlFileName>
<LongName> 9954570 - Disclosure - Collaborative and Other Relationships - Pretax Profit Sharing Formula (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsPretaxProfitSharingFormulaDetails </Role>
<ShortName> Collaborative and Other Relationships - Pretax Profit Sharing Formula (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 135 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R136.htm </HtmlFileName>
<LongName> 9954571 - Disclosure - Collaborative and Other Relationships - Revenues from Anti-CD20 Therapeutic Programs (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsRevenuesfromAntiCD20TherapeuticProgramsDetails </Role>
<ShortName> Collaborative and Other Relationships - Revenues from Anti-CD20 Therapeutic Programs (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 136 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R137.htm </HtmlFileName>
<LongName> 9954572 - Disclosure - Collaborative and Other Relationships - Ionis (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsIonisDetails </Role>
<ShortName> Collaborative and Other Relationships - Ionis (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsTables </ParentRole>
<Position> 137 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R138.htm </HtmlFileName>
<LongName> 9954573 - Disclosure - Collaborative and Other Relationships - Eisai (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsEisaiDetails </Role>
<ShortName> Collaborative and Other Relationships - Eisai (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsTables </ParentRole>
<Position> 138 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R139.htm </HtmlFileName>
<LongName> 9954574 - Disclosure - Collaborative and Other Relationships - Summary of Activity Related to BAN2401 and Elenbecestat Collaboration (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsSummaryofActivityRelatedtoBAN2401andElenbecestatCollaborationDetails </Role>
<ShortName> Collaborative and Other Relationships - Summary of Activity Related to BAN2401 and Elenbecestat Collaboration (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 139 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R140.htm </HtmlFileName>
<LongName> 9954575 - Disclosure - Collaborative and Other Relationships - ADUHELM Collaboration Agreement (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsADUHELMCollaborationAgreementDetails </Role>
<ShortName> Collaborative and Other Relationships - ADUHELM Collaboration Agreement (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 140 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R141.htm </HtmlFileName>
<LongName> 9954576 - Disclosure - Collaborative and Other Relationships - Summary of Activity Related to Aducanumab Collaboration (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsSummaryofActivityRelatedtoAducanumabCollaborationDetails </Role>
<ShortName> Collaborative and Other Relationships - Summary of Activity Related to Aducanumab Collaboration (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 141 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R142.htm </HtmlFileName>
<LongName> 9954577 - Disclosure - Collaborative and Other Relationships - Summary of Activity Related to the UCB Collaboration (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsSummaryofActivityRelatedtotheUCBCollaborationDetails </Role>
<ShortName> Collaborative and Other Relationships - Summary of Activity Related to the UCB Collaboration (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 142 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R143.htm </HtmlFileName>
<LongName> 9954578 - Disclosure - Collaborative and Other Relationships - Alkermes (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsAlkermesDetails </Role>
<ShortName> Collaborative and Other Relationships - Alkermes (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 143 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R144.htm </HtmlFileName>
<LongName> 9954579 - Disclosure - Collaborative and Other Relationships - Acorda (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsAcordaDetails </Role>
<ShortName> Collaborative and Other Relationships - Acorda (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsTables </ParentRole>
<Position> 144 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R145.htm </HtmlFileName>
<LongName> 9954580 - Disclosure - Collaborative and Other Relationships - Other Arrangements (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsOtherArrangementsDetails </Role>
<ShortName> Collaborative and Other Relationships - Other Arrangements (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 145 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R146.htm </HtmlFileName>
<LongName> 9954581 - Disclosure - Collaborative and Other Relationships - Summary of Activity Related to Sage Therapeutics (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsSummaryofActivityRelatedtoSageTherapeuticsDetails </Role>
<ShortName> Collaborative and Other Relationships - Summary of Activity Related to Sage Therapeutics (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 146 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R147.htm </HtmlFileName>
<LongName> 9954582 - Disclosure - Collaborative and Other Relationships - Summary of Activity Related To Denali Therapeutics (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsSummaryofActivityRelatedToDenaliTherapeuticsDetails </Role>
<ShortName> Collaborative and Other Relationships - Summary of Activity Related To Denali Therapeutics (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 147 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R148.htm </HtmlFileName>
<LongName> 9954583 - Disclosure - Collaborative and Other Relationships - Summary of Activity Related to Sangamo Therapeutics (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsSummaryofActivityRelatedtoSangamoTherapeuticsDetails </Role>
<ShortName> Collaborative and Other Relationships - Summary of Activity Related to Sangamo Therapeutics (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 148 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R149.htm </HtmlFileName>
<LongName> 9954584 - Disclosure - Collaborative and Other Relationships - Samsung Bioepis (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CollaborativeandOtherRelationshipsSamsungBioepisDetails </Role>
<ShortName> Collaborative and Other Relationships - Samsung Bioepis (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 149 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R150.htm </HtmlFileName>
<LongName> 9954585 - Disclosure - Investments in Variable Interest Entities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/InvestmentsinVariableInterestEntitiesDetails </Role>
<ShortName> Investments in Variable Interest Entities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/InvestmentsinVariableInterestEntities </ParentRole>
<Position> 150 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R151.htm </HtmlFileName>
<LongName> 9954586 - Disclosure - Litigation (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/LitigationDetails </Role>
<ShortName> Litigation (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/Litigation </ParentRole>
<Position> 151 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R152.htm </HtmlFileName>
<LongName> 9954587 - Disclosure - Commitments and Contingencies (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/CommitmentsandContingenciesDetails </Role>
<ShortName> Commitments and Contingencies (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/CommitmentsandContingencies </ParentRole>
<Position> 152 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R153.htm </HtmlFileName>
<LongName> 9954588 - Disclosure - Employee Benefit Plans (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/EmployeeBenefitPlansDetails </Role>
<ShortName> Employee Benefit Plans (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://www.biogenidec.com/role/EmployeeBenefitPlans </ParentRole>
<Position> 153 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R154.htm </HtmlFileName>
<LongName> 9954589 - Disclosure - Segment Information - Narrative (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/SegmentInformationNarrativeDetails </Role>
<ShortName> Segment Information - Narrative (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 154 </Position>
</Report>
<Report instance="biib-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R155.htm </HtmlFileName>
<LongName> 9954590 - Disclosure - Segment Information - Geographic Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://www.biogenidec.com/role/SegmentInformationGeographicInformationDetails </Role>
<ShortName> Segment Information - Geographic Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 155 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="biib-20231231.htm"> biib-20231231.htm </File>
<File> biib-20231231.xsd </File>
<File> biib-20231231_cal.xml </File>
<File> biib-20231231_def.xml </File>
<File> biib-20231231_lab.xml </File>
<File> biib-20231231_pre.xml </File>
</InputFiles>
<SupplementalFiles>
<File> biib-20231231_g1.jpg </File>
<File> biib-20231231_g10.jpg </File>
<File> biib-20231231_g11.jpg </File>
<File> biib-20231231_g12.jpg </File>
<File> biib-20231231_g13.jpg </File>
<File> biib-20231231_g14.jpg </File>
<File> biib-20231231_g15.jpg </File>
<File> biib-20231231_g16.jpg </File>
<File> biib-20231231_g17.jpg </File>
<File> biib-20231231_g18.jpg </File>
<File> biib-20231231_g19.jpg </File>
<File> biib-20231231_g2.jpg </File>
<File> biib-20231231_g20.jpg </File>
<File> biib-20231231_g21.jpg </File>
<File> biib-20231231_g22.jpg </File>
<File> biib-20231231_g23.jpg </File>
<File> biib-20231231_g24.jpg </File>
<File> biib-20231231_g25.jpg </File>
<File> biib-20231231_g26.jpg </File>
<File> biib-20231231_g27.jpg </File>
<File> biib-20231231_g28.jpg </File>
<File> biib-20231231_g29.jpg </File>
<File> biib-20231231_g3.jpg </File>
<File> biib-20231231_g30.jpg </File>
<File> biib-20231231_g31.jpg </File>
<File> biib-20231231_g32.jpg </File>
<File> biib-20231231_g33.jpg </File>
<File> biib-20231231_g34.jpg </File>
<File> biib-20231231_g4.jpg </File>
<File> biib-20231231_g5.jpg </File>
<File> biib-20231231_g6.jpg </File>
<File> biib-20231231_g7.jpg </File>
<File> biib-20231231_g8.jpg </File>
<File> biib-20231231_g9.jpg </File>
</SupplementalFiles>
<BaseTaxonomies>
<BaseTaxonomy items="2056"> http://fasb.org/us-gaap/2023 </BaseTaxonomy>
<BaseTaxonomy items="38"> http://xbrl.sec.gov/dei/2023 </BaseTaxonomy>
<BaseTaxonomy items="10"> http://xbrl.sec.gov/ecd/2023 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

29 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/12/23  Biogen Inc.                       8-K:5,9    12/06/23   12:801K                                   Donnelley … Solutions/FA
 9/01/23  Biogen Inc.                       8-K:1,2,9   8/28/23   11:840K                                   Donnelley … Solutions/FA
 7/31/23  Biogen Inc.                       8-K:1,5,9   7/28/23   15:1.3M                                   Donnelley … Solutions/FA
 4/25/23  Biogen Inc.                       10-Q        3/31/23  104:12M
 2/15/23  Biogen Inc.                       10-K       12/31/22  170:30M
11/10/22  Biogen Inc.                       8-K:5,7,9  11/10/22   12:405K                                   Donnelley … Solutions/FA
 5/03/22  Biogen Inc.                       10-Q        3/31/22   97:13M
 6/08/21  Biogen Inc.                       8-K:5,9     6/02/21   12:286K
 2/16/21  Biogen Inc.                       8-K:8,9     2/16/21   14:596K                                   Donnelley … Solutions/FA
10/21/20  Biogen Inc.                       10-Q        9/30/20   97:19M
 4/30/20  Biogen Inc.                       8-K:8,9     4/27/20   13:524K                                   Donnelley … Solutions/FA
 2/03/20  Biogen Inc.                       8-K:1,2,9   1/28/20   11:934K                                   Donnelley … Solutions/FA
10/22/19  Biogen Inc.                       10-Q        9/30/19   99:17M
 7/24/19  Biogen Inc.                       10-Q        6/30/19  104:17M
 4/24/19  Biogen Inc.                       10-Q        3/31/19   98:11M
 4/24/18  Biogen Inc.                       10-Q        3/31/18   97:12M
 2/01/18  Biogen Inc.                       10-K       12/31/17  145:22M
 7/25/17  Biogen Inc.                       10-Q        6/30/17   92:11M
 4/26/17  Biogen Inc.                       DEF 14A     6/07/17    1:2.4M                                   Donnelley … Solutions/FA
 2/03/16  Biogen Inc.                       10-K       12/31/15  144:22M
 9/16/15  Biogen Inc.                       8-K:8,9     9/15/15    3:488K                                   Donnelley … Solutions/FA
 4/30/15  Biogen Inc.                       DEF 14A     6/10/15    1:3M                                     Donnelley … Solutions/FA
 3/27/15  Biogen Inc.                       8-K:5,9     3/27/15    3:329K
 7/24/12  Biogen Inc.                       10-Q        6/30/12   95:8.8M                                   Donnelley … Solutions/FA
 6/07/11  Biogen Inc.                       8-K:1,5,9   6/01/11    4:131K                                   Donnelley … Solutions/FA
 2/04/11  Biogen Inc.                       10-K       12/31/10  124:24M                                    Donnelley … Solutions/FA
 2/09/10  Biogen Inc.                       10-K       12/31/09   48:6.2M                                   Donnelley … Solutions/FA
 5/08/08  Biogen Inc.                       DEFC14A     5/08/08    1:1.1M Biogen Inc.                       Bowne of Boston/FA
 3/10/04  Biogen Inc.                       10-K       12/31/03   31:1.7M                                   Bowne of Boston/FA
↑Top
Filing Submission 0000875045-24-000009   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., May 9, 11:36:42.2pm ET